Study guide
10.3 Glycogen Metabolism, Gluconeogenesis, and Pentose Phosphate Pathway
NPLEX Part I — Biomedical Sciences Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Pacing, and GEA Strategy
1.1 Overview of NPLEX Part I & NABNE Exam Structure 1.2 Deconstructing Biomedical Clinical Vignettes 1.3 General Exam Areas (GEAs) & Passing Standards
2 Chapter 2: Gross Anatomy & Musculoskeletal System
2.1 Musculoskeletal Anatomy of Upper and Lower Extremities 2.2 Structural Anatomy of Head, Neck, Thorax, and Abdomen 2.3 Pelvic Architecture, Perineal Anatomy, and Articular Structures
3 Chapter 3: Histology & Microscopic Anatomy
3.1 Histology of Epithelial, Connective, and Muscular Tissues 3.2 Microscopic Structure of Gastrointestinal, Renal, and Endocrine Organs 3.3 Microscopic Anatomy of Integument, Lymphoid Tissues, and Respiratory Epithelium
4 Chapter 4: Neuroanatomy & Special Senses
4.1 Cranial Nerves, Nuclei, and Peripheral Distribution 4.2 Spinal Cord Tracts, Brainstem Circuits, and Motor/Sensory Pathways 4.3 Cerebral Cortex, Basal Ganglia, Limbic System, and Autonomic Nervous System 4.4 Neuroanatomy of Vision, Audition, Vestibular Function, and Olfaction/Gustation
5 Chapter 5: Embryology & Developmental Anatomy
5.1 Gametogenesis, Fertilization, Blastulation, and Germ Layer Derivatives 5.2 Organogenesis: Cardiovascular and Respiratory System Development 5.3 Gastrointestinal, Urogenital, and Craniofacial Embryology
6 Chapter 6: Cellular & General Physiology
6.1 Membrane Transport Mechanics, Resting Potentials, and Ion Channels 6.2 Action Potential Propagation and Synaptic Transmission 6.3 Excitation-Contraction Coupling in Skeletal, Cardiac, and Smooth Muscle
7 Chapter 7: Cardiovascular & Respiratory Physiology
7.1 Cardiac Electrophysiology, ECG, and Mechanical Cardiac Cycle 7.2 Hemodynamics, Peripheral Resistance, and Blood Pressure Control 7.3 Pulmonary Mechanics, Lung Volumes, and Gas Exchange Dynamics 7.4 Transport of Oxygen/CO2 and Neural/Chemical Control of Breathing
8 Chapter 8: Renal, Fluid, & Acid-Base Physiology
8.1 Glomerular Filtration Rate and Tubular Reabsorption/Secretion Mechanics 8.2 Countercurrent Multiplication, Osmoregulation, and Urine Concentration 8.3 Body Fluid Compartments, Sodium/Water Homeostasis, and Potassium Dynamics 8.4 Renal & Respiratory Acid-Base Regulation and Compensation Mechanisms
9 Chapter 9: Gastrointestinal, Endocrine, & Reproductive Physiology
9.1 GI Motility, Secretory Functions, Digestion, and Nutrient Absorption 9.2 Hypothalamic-Pituitary Axes, Adrenal Gland, and Thyroid Physiology 9.3 Endocrine Pancreas, Glucose Regulation, Calcium/Phosphate Homeostasis 9.4 Male and Female Reproductive Endocrinology and Menstrual Cycle Regulation
10 Chapter 10: Enzymology, Bioenergetics, & Carbohydrate/Lipid Metabolism
10.1 Enzyme Kinetics, Catalytic Mechanisms, and Vitamin Cofactors 10.2 Glycolysis, Pyruvate Dehydrogenase, TCA Cycle, and Oxidative Phosphorylation 10.3 Glycogen Metabolism, Gluconeogenesis, and Pentose Phosphate Pathway 10.4 Fatty Acid Synthesis, Beta-Oxidation, Ketogenesis, and Lipoprotein Transport
11 Chapter 11: Amino Acid/Nucleotide Metabolism & Clinical Genetics
11.1 Amino Acid Degradation, Transamination, and Urea Cycle Disorders 11.2 Purine and Pyrimidine Synthesis, Salvage, and Gout Pathophysiology 11.3 Mendelian Inheritance, Chromosomal Abnormalities, and Molecular Genetics
12 Chapter 12: Immunology & Immunopathology
12.1 Innate Immune Barriers, Phagocytosis, Cellular Pattern Recognition, and Complement System 12.2 Adaptive Immunity: T-Cell & B-Cell Activation, MHC Restriction, and Antibodies 12.3 Types I-IV Hypersensitivity Reactions and Mechanisms of Autoimmunity 12.4 Immunodeficiency Syndromes, Tumor/Transplant Immunology, and Vaccine Types
13 Chapter 13: Medical Microbiology
13.1 Medical Bacteriology: Gram-Positive, Gram-Negative, and Atypical Bacteria 13.2 Medical Virology: DNA, RNA, Retroviruses, and Viral Pathogenesis 13.3 Medical Mycology: Cutaneous, Systemic, and Opportunistic Fungal Infections 13.4 Medical Parasitology: Protozoan and Helminthic Pathogens
14 Chapter 14: General Pathology & Neoplasia
14.1 Cellular Adaptation, Reversible/Irreversible Injury, Necrosis, and Apoptosis 14.2 Acute and Chronic Inflammation, Chemical Mediators, and Tissue Healing 14.3 Neoplasia: Benign vs Malignant Features, Carcinogenesis, Oncogenes, and Tumor Suppressors
15 Chapter 15: Systems Pathology & Disease Mechanisms
15.1 Pathophysiology of Atherosclerosis, Heart Failure, COPD, and Pneumonias 15.2 Glomerulonephritis, Inflammatory Bowel Disease, and Hepatorenal Disease Pathophysiology 15.3 Endocrine Disorders, Neurodegenerative Pathology, and Epidemiological Principles 15.4 Hematopoietic System Pathology: Anemias, Coagulopathies, and Hematologic Neoplasms 15.5 Immunological System Pathology: Autoimmune, Amyloid, and Systemic Immune-Mediated Disease 15.6 Integumentary System Pathology: Inflammatory Dermatoses, Blistering Disorders, and Skin Neoplasms 15.7 Musculoskeletal System Pathology: Metabolic Bone Disease, Arthropathies, and Bone Neoplasms 15.8 Reproductive System Pathology: Endocrine, Inflammatory, and Neoplastic Disorders of the Reproductive Tract
10.3 Glycogen Metabolism, Gluconeogenesis, and Pentose Phosphate Pathway
Key Takeaways Explain This Topic AI
Glycogen metabolism is reciprocally regulated by phosphorylation: Glycogen Synthase (glycogenesis) is activated by dephosphorylation/insulin, whereas Glycogen Phosphorylase (glycogenolysis) is activated by phosphorylation/glucagon/epinephrine.
Glycogen Storage Diseases exhibit distinct clinical presentations, including Von Gierke disease (Type I: Glucose-6-Phosphatase deficiency with severe hypoglycemia/lactic acidosis), Pompe disease (Type II: Lysosomal acid maltase deficiency with cardiomegaly), and McArdle disease (Type V: Muscle phosphorylase deficiency with exercise cramps/myoglobinuria).
Gluconeogenesis bypasses the three irreversible steps of glycolysis in the liver and kidney using Pyruvate Carboxylase, PEPCK, Fructose-1,6-Bisphosphatase (rate-limiting), and Glucose-6-Phosphatase.
The Pentose Phosphate Pathway generates NADPH for reductive biosynthesis/antioxidant defense via G6PD (rate-limiting); G6PD deficiency triggers oxidative hemolytic anemia with Heinz bodies and Bite cells upon exposure to fava beans or oxidative drugs.
Last updated: July 2026
10.3 Glycogen Metabolism, Gluconeogenesis, and Pentose Phosphate Pathway
Glucose homeostasis relies on dynamic balancing between storage (glycogenesis), mobilization (glycogenolysis), de novo synthesis (gluconeogenesis), and alternative shunt pathways (pentose phosphate pathway). Mastery of these metabolic pathways and their clinical genetic disorders is essential for NPLEX Part I candidates.
Glycogen Metabolism & Reciprocal Regulation
Glycogen is a branched polymer of glucose stored predominantly in the liver (maintains systemic blood glucose during fasting) and skeletal muscle (provides immediate fuel for muscle contraction).
Linkages: Linear chains consist of α \alpha α -1,4 glycosidic bonds ; branches occur every 8–12 residues via α \alpha α -1,6 glycosidic bonds .
Glycogenesis (Glycogen Synthesis)
Pathway: Glucose → \rightarrow → G6P → \rightarrow → G1P → \rightarrow → UDP-Glucose (catalyzed by UDP-glucose pyrophosphorylase).
Rate-Limiting Enzyme: Glycogen Synthase , which adds UDP-glucose to the non-reducing ends of glycogen chains via α \alpha α -1,4 bonds.
Branching Enzyme: Amylo-( 1 , 4 → 1 , 6 1,4 \rightarrow 1,6 1 , 4 → 1 , 6 )-transglucosidase creates α \alpha α -1,6 branch points.
Hormonal Regulation: Activated by Insulin (fed state). Insulin stimulates protein phosphatase-1 (PP-1), which dephosphorylates Glycogen Synthase, converting it to its active (a) form . Activated allosterically by Glucose-6-Phosphate .
Glycogenolysis (Glycogen Breakdown)
Rate-Limiting Enzyme: Glycogen Phosphorylase , which cleaves α \alpha α -1,4 linkages via phosphorolysis, releasing Glucose-1-Phosphate (G1P) until 4 glucose residues remain before a branch point (a limit dextrin ).
Debranching Enzyme: A bifunctional protein possessing:
4- α \alpha α -D-glucanotransferase: Transfers 3 terminal glucose residues from the branch to an adjacent linear chain.
α \alpha α -1,6-glucosidase: Hydrolytically cleaves the single remaining α \alpha α -1,6 linked glucose residue, releasing free glucose .
Hormonal / Allosteric Regulation: Activated by Glucagon (liver) and Epinephrine (liver and muscle) via cAMP / Protein Kinase A (PKA) cascade. PKA phosphorylates Glycogen Phosphorylase Kinase, which phosphorylates Glycogen Phosphorylase into its active (a) form .
Muscle-Specific Allosteric Activation: Activated by AMP and Ca 2 + \text{Ca}^{2+} Ca 2 + (via calmodulin subunit), signaling active muscle contraction without requiring hormonal input.
Glycogen Storage Diseases (GSDs)
Inherited enzyme deficiencies in glycogen synthesis or breakdown result in distinctive organomegaly, hypoglycemia, or muscle weakness.
Type Disease Name Deficient Enzyme Major Clinical Features & Pathophysiology
Type I Von Gierke Disease Glucose-6-Phosphatase Severe fasting hypoglycemia , marked hepatomegaly , lactic acidosis (impaired gluconeogenesis forces pyruvate to lactate), hyperuricemia (gout due to elevated G6P diverting to HMP shunt → \rightarrow → purines), hyperlipidemia. Renal enlargement.
Type II Pompe Disease Lysosomal α \alpha α -1,4-glucosidase (Acid Maltase) Cardiomegaly , hypertrophic cardiomyopathy, severe hypotonia ("floppy infant"), respiratory distress, early death. Glycogen accumulates in lysosomes. (Mnemonic: Pompe affects the Pump/Heart ).
Type III Cori Disease Debranching Enzyme (4- α \alpha α -glucanotransferase / α \alpha α -1,6-glucosidase) Milder form of Von Gierke with fasting hypoglycemia and hepatomegaly, but normal blood lactate levels. Accumulation of limit dextrin-like structures in liver.
Type IV Andersen Disease Branching Enzyme Infantile cirrhosis, progressive hepatosplenomegaly, failure to thrive, early mortality. Accumulation of poorly branched glycogen (amylopectin-like).
Type V McArdle Disease Skeletal Muscle Glycogen Phosphorylase (Myophosphorylase) Painful muscle cramps and second-wind phenomenon during strenuous exercise, myoglobinuria (rhabdomyolysis → \rightarrow → red-brown urine), risk of renal failure. Normal liver glycogen and normal blood glucose.
Gluconeogenesis: De Novo Glucose Synthesis
Occurring primarily in the liver (and to a lesser extent in the kidney cortex during prolonged starvation), gluconeogenesis synthesizes glucose from non-carbohydrate precursors: Lactate , Glycerol (from adipose triglyceride breakdown), and Glucogenic Amino Acids (predominantly Alanine and Glutamine).
Bypassing the 3 Irreversible Glycolytic Steps
To drive flux in the anabolic direction, gluconeogenesis uses 4 unique enzymes to bypass the 3 thermodynamically irreversible steps of glycolysis: Glycolysis Step 10: PEP ──────────► Pyruvate
Gluconeogenesis Bypass 1:
- 1a. Pyruvate (Mitochondria) + CO2 + ATP ──[Pyruvate Carboxylase (B7)]──► Oxaloacetate
- 1b. Oxaloacetate + GTP ──[PEP Carboxykinase (PEPCK)]──► Phosphoenolpyruvate (PEP)
Glycolysis Step 3: Fructose-6-P ──► Fructose-1,6-BP
Gluconeogenesis Bypass 2 (RATE-LIMITING STEP):
Fructose-1,6-BP + H2O ──[Fructose-1,6-Bisphosphatase]──► Fructose-6-P + Pi
Glycolysis Step 1: Glucose ───────► Glucose-6-P
Gluconeogenesis Bypass 3:
Glucose-6-P + H2O ──[Glucose-6-Phosphatase (ER Membrane)]──► Free Glucose + Pi
Fructose-1,6-Bisphosphatase (FBPase-1): The primary rate-limiting enzyme of gluconeogenesis.
Inhibited by: Fructose-2,6-bisphosphate (F2,6BP) and AMP .
Activated by: Citrate and ATP (signaling energy surplus).
Glucose-6-Phosphatase: Embedded in the endoplasmic reticulum membrane of liver and kidney cells; absent in skeletal muscle (explaining why muscle glycogen cannot directly contribute to systemic blood glucose).
Pentose Phosphate Pathway (HMP Shunt)
Occurring entirely in the cytoplasm, the Pentose Phosphate Pathway (Hexose Monophosphate Shunt) branches from Glucose-6-Phosphate. It produces NADPH and Ribose-5-phosphate without consuming or generating ATP.
Two Phases of the HMP Shunt
Irreversible Oxidative Phase:
Rate-Limiting Enzyme: Glucose-6-Phosphate Dehydrogenase (G6PD) .
Converts Glucose-6-P → \rightarrow → Ribulose-5-P, producing 2 NADPH and 1 CO 2 \text{CO}_2 CO 2 .
Induced by Insulin; inhibited by high NADPH / NADP + \text{NADPH}/\text{NADP}^+ NADPH / NADP + ratio.
Reversible Non-Oxidative Phase:
Catalyzed by Transketolase (requires Vitamin B1 Thiamine ) and Transaldolase.
Interconverts pentose phosphates with glycolytic intermediates (Glyceraldehyde-3-P and Fructose-6-P).
Cellular Functions of NADPH
Reductive Biosynthesis: Fatty acid, cholesterol, and steroid hormone synthesis.
Antioxidant Defense: Maintenance of reduced Glutathione ( GSH \text{GSH} GSH ) via Glutathione Reductase, protecting cell membranes against reactive oxygen species ( H 2 O 2 \text{H}_2\text{O}_2 H 2 O 2 ).
Phagocytic Respiratory Burst: Substrate for NADPH \text{NADPH} NADPH Oxidase in neutrophils producing superoxide radicals for bacterial killing.
G6PD Deficiency
Genetics: X-linked recessive disorder; most common enzymatic disorder worldwide.
Pathophysiology: Decreased G6PD activity → \rightarrow → insufficient NADPH production in erythrocyte cytosol → \rightarrow → inability to regenerate reduced glutathione ( GSH \text{GSH} GSH ) → \rightarrow → accumulation of reactive oxygen species during oxidative stress → \rightarrow → oxidation of hemoglobin sulfhydryl groups.
Histological & Microscopic Features:
Heinz Bodies: Denatured, precipitated hemoglobin aggregates visible on crystal violet stain.
Bite Cells (Degmacytes): Splenic macrophages pluck out Heinz bodies as RBCs pass through cords of Billroth.
Triggers of Acute Hemolytic Episodes:
Fava beans (favism).
Infections (most common trigger; neutrophils release free radicals).
Oxidative Drugs: Antimalarials (Primaquine), Sulfa drugs (Sulfamethoxazole), Nitrofurantoin, Rasburicase.